Ironwood Pharmaceuticals Net Profit Margin 2009-2020 | IRWD

Ironwood Pharmaceuticals net profit margin from 2009 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Ironwood Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-03-31 $0.44B $0.05B 10.48%
2019-12-31 $0.43B $0.02B 4.91%
2019-09-30 $0.43B $-0.00B -0.92%
2019-06-30 $0.37B $-0.20B -54.08%
2019-03-31 $0.35B $-0.26B -74.93%
2018-12-31 $0.35B $-0.28B -80.98%
2018-09-30 $0.31B $-0.25B -81.94%
2018-06-30 $0.33B $-0.11B -33.84%
2018-03-31 $0.32B $-0.11B -33.97%
2017-12-31 $0.30B $-0.12B -39.26%
2017-09-30 $0.29B $-0.14B -49.14%
2017-06-30 $0.27B $-0.14B -53.33%
2017-03-31 $0.26B $-0.12B -47.10%
2016-12-31 $0.27B $-0.08B -30.04%
2016-09-30 $0.24B $-0.08B -34.31%
2016-06-30 $0.21B $-0.10B -45.07%
2016-03-31 $0.19B $-0.12B -65.24%
2015-12-31 $0.15B $-0.14B -94.67%
2015-09-30 $0.14B $-0.17B -122.96%
2015-06-30 $0.11B $-0.16B -143.75%
2015-03-31 $0.09B $-0.17B -190.11%
2014-12-31 $0.08B $-0.19B -246.75%
2014-09-30 $0.04B $-0.20B -463.64%
2014-06-30 $0.03B $-0.22B -700.00%
2014-03-31 $0.04B $-0.23B -654.29%
2013-12-31 $0.02B $-0.27B -1186.96%
2013-09-30 $0.05B $-0.27B -588.89%
2013-06-30 $0.14B $-0.16B -113.97%
2013-03-31 $0.14B $-0.13B -92.91%
2012-12-31 $0.15B $-0.07B -48.67%
2012-09-30 $0.16B $-0.04B -23.23%
2012-06-30 $0.07B $-0.11B -147.89%
2012-03-31 $0.07B $-0.08B -123.88%
2011-12-31 $0.07B $-0.07B -100.00%
2011-09-30 $0.05B $-0.07B -140.00%
2011-06-30 $0.05B $-0.06B -121.28%
2011-03-31 $0.05B $-0.06B -122.22%
2010-12-31 $0.04B $-0.05B -120.45%
2010-09-30 $0.03B $-0.07B -191.18%
2010-06-30 $0.04B $-0.07B -170.00%
2010-03-31 $0.04B $-0.07B -181.58%
2009-12-31 $0.03B $-0.07B -208.82%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.629B $0.428B
Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation and chronic constipation. The Company also focuses on one Phase 1 pain drug candidate and multiple preclinical programs, as well as on building a specialty biochemicals business based on a proprietary strain-development platform. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.682B 37.84
Takeda Pharmaceutical (TAK) Japan $54.637B 9.57
Astellas Pharma (ALPMY) Japan $29.826B 15.11
UCB SA (UCBJF) Belgium $24.547B 0.00
Eisai (ESALY) Japan $23.752B 20.59
Merck (MKGAF) Germany $16.026B 21.02
Grifols, S.A (GRFS) Spain $13.215B 16.43
Catalent (CTLT) United States $12.286B 47.50
Neurocrine Biosciences (NBIX) United States $12.176B 56.28
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.568B 45.56
IPSEN SA ADR (IPSEY) France $7.709B 0.00
Orion OYJ (ORINY) Finland $7.077B 31.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.349B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.939B 9.50
United Therapeutics (UTHR) United States $5.210B 9.87
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.818B 526.00
Nektar Therapeutics (NKTR) United States $4.199B 0.00
Evotec AG (EVTCY) Germany $4.040B 108.88
FibroGen (FGEN) United States $3.748B 0.00
Hypermarcas (HYPMY) Brazil $3.724B 13.70
ChemoCentryx (CCXI) United States $3.625B 0.00
PTC Therapeutics (PTCT) United States $3.566B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.505B 10.29
Pacira BioSciences (PCRX) United States $2.331B 47.70
Sage Therapeutics (SAGE) United States $2.266B 0.00
Cronos Group (CRON) Canada $2.233B 64.00
Corcept Therapeutics (CORT) United States $1.869B 18.53
Xencor (XNCR) United States $1.825B 0.00
USANA Health Sciences (USNA) United States $1.786B 18.32
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.631B 0.00
Akebia Therapeutics (AKBA) United States $1.551B 0.00
Zogenix (ZGNX) United States $1.516B 0.00
Heron Therapeutics (HRTX) United States $1.487B 0.00
Indivior (INVVY) United States $1.421B 17.64
Karyopharm Therapeutics (KPTI) United States $1.412B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.398B 15.06
Theravance Biopharma (TBPH) Cayman Islands $1.339B 0.00
Esperion Therapeutics (ESPR) United States $1.310B 0.00
VAXART, INC (VXRT) United States $1.259B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.200B 0.00
Translate Bio (TBIO) United States $1.164B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.034B 46.13
Tilray (TLRY) Canada $0.945B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.923B 0.00
Endo (ENDP) Ireland $0.774B 1.20
ImmunoGen (IMGN) United States $0.749B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.695B 0.00
Trillium Therapeutics (TRIL) Canada $0.622B 0.00
Radius Health (RDUS) United States $0.614B 0.00
Aerie Pharmaceuticals (AERI) United States $0.611B 0.00
Collegium Pharmaceutical (COLL) United States $0.572B 0.00
Ardelyx (ARDX) United States $0.568B 0.00
Molecular Templates (MTEM) United States $0.558B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.524B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.513B 12.40
Flexion Therapeutics (FLXN) United States $0.506B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.500B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.481B 18.78
Siga Technologies (SIGA) United States $0.477B 0.00
Altimmune (ALT) United States $0.451B 0.00
DURECT (DRRX) United States $0.419B 0.00
TherapeuticsMD (TXMD) United States $0.405B 0.00
Ocular Therapeutix (OCUL) United States $0.403B 0.00
Harpoon Therapeutics (HARP) United States $0.376B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.373B 0.00
MEI Pharma (MEIP) United States $0.359B 0.00
Calithera Biosciences (CALA) United States $0.359B 0.00
Organogenesis Holdings (ORGO) United States $0.349B 0.00
Concert Pharmaceuticals (CNCE) United States $0.303B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.287B 0.00
IMV INC (IMV) Canada $0.286B 0.00
PROFOUND MEDICL (PROF) Canada $0.267B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.253B 0.00
Taiwan Liposome (TLC) Taiwan $0.231B 0.00
Redhill Biopharma (RDHL) Israel $0.225B 0.00
OptiNose (OPTN) United States $0.218B 0.00
CASI Pharmaceuticals (CASI) United States $0.212B 0.00
Rafael Holdings (RFL) United States $0.208B 0.00
KalVista Pharmaceuticals (KALV) United States $0.206B 0.00
Lannett Co Inc (LCI) United States $0.198B 4.34
Nature's Sunshine Products (NATR) United States $0.188B 24.77
Jounce Therapeutics (JNCE) United States $0.174B 4.16
Nivalis Therapeutics (ALPN) United States $0.168B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.149B 0.00
Aquestive Therapeutics (AQST) United States $0.139B 0.00
Otonomy (OTIC) United States $0.124B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.117B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.114B 0.00
Xeris Pharmaceuticals (XERS) United States $0.106B 0.00
Champions Oncology (CSBR) United States $0.105B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.103B 0.00
MediWound (MDWD) Israel $0.103B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Heat Biologics (HTBX) United States $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.100B 0.00
Recro Pharma (REPH) United States $0.098B 0.00
Onconova Therapeutics (ONTX) United States $0.094B 0.00
CTI BioPharma (CTIC) United States $0.092B 0.00
Sundial Growers (SNDL) Canada $0.090B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.090B 0.00
Biomerica (BMRA) United States $0.086B 0.00
Hemispherx BioPharma (AIM) United States $0.085B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.082B 0.00
ElectroCore (ECOR) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
Lipocine (LPCN) United States $0.059B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
CV Sciences (CVSI) United States $0.056B 0.00
PolarityTE (PTE) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 28.91
Natural Alternatives (NAII) United States $0.047B 0.00
Infinity Pharmaceuticals (INFI) United States $0.047B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.045B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
IsoRay (ISR) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Mannatechorporated (MTEX) United States $0.041B 7.70
Novan (NOVN) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 85.18
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Jaguar Animal Health (JAGX) United States $0.037B 0.00
GTx (ONCT) United States $0.036B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.033B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.018B 0.00
Iterum Therapeutics (ITRM) Ireland $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Can-Fite Biopharma (CANF) Israel $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 31.57
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Shineco (TYHT) China $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.008B 0.00
Vical (BBI) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00